Atossa Therapeutics

ATOSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$22.453 M

$2.25 +1.35%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$34.8M

Loss-making

Shares outstanding

9,979,298

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#389Cocrystal PharmaCOCP$22.9M
#390Aytu BiopharmaAYTU$22.8M
#391Atossa TherapeuticsATOS$22.5M
#392Cellectar BiosciencesCLRB$22.2M
#393Korsana BiosciencesKRSA$22.2M

What if Atossa Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$3,033,686

Per share 1,348,305× higher

Bitcoin $1.72T

$172,337.14

Per share 76,594× higher

Nvidia $5.48T

$549,122.58

Per share 244,054× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Atossa Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.